A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer.
MINNEAPOLIS – A large, new study shows no evidence that exercise may reduce a woman’s risk of developing multiple sclerosis (MS). The research is published in the September 28, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Previous small studies had shown conflicting results.
One in 6 women in the U.S. takes antidepressants to improve her well-being, but what is she to do when the medication that is meant to help disrupts another area of her life?
Mayo Clinic physicians will present findings at the 2016 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting Sept. 25-28 in Boston.
It has been 50 years since Leonard Kurland, M.D., came from the National Institutes of Health (NIH) to Rochester and established what would become a world-class, but often overlooked, gem in health care research: the Rochester Epidemiology Project (REP).
In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.
ROCHESTER, Minn. — What’s often been considered the next generation of health care is here now —ready to arrive at your doctor’s office. Experts in individualized medicine — also known as personalized or precision medicine — will be in Rochester on Oct. 5-6, 2016, presenting ways to integrate genomic medicine into patient care. They will offer the latest findings at Individualizing Medicine 2016: Advancing Care Through Genomics which will be held at the Rochester Civic Center. If you’re a member of the media, you’re invited to interview these experts on-site or cover their presentations via webcast or Facebook Live for a variety of health and medical stories.
ROCHESTER, Minn. — Individualized medicine, also known as precision or personalized medicine, is the concept that prediction, diagnosis, treatment and, eventually, prevention can be matched to an individual patient based on genetics, environment and lifestyle. The Mayo Clinic Center for Individualized Medicine is a catalyst in moving personalized medicine from the laboratory to clinical care.
Researchers in the University of Minnesota’s College of Science and Engineering have measured the twisting force, or torque, generated by light on a silicon chip. Their work holds promise for applications such as miniaturized gyroscopes and torsional sensors to measure magnetic field, which can have significant industrial and consumer impact.
A global genetic interaction map is revolutionizing how genes are being studied. A new study is no longer looking at genes as loners, but instead as a social network of the body, interacting in groups. The new approach may ultimately change our understanding of the genetic roots of diseases.
BETHESDA, Md., and ROCHESTER, Minn. — The American Society of Human Genetics (ASHG) and Mayo Clinic Center for Individualized Medicine (CIM) announced today a formal collaboration under which the two organizations will facilitate the use of genomics in medicine through the education of health professionals.
An article published today in the New England Journal of Medicine updates the medical community on a potentially devastating liver disease that afflicts approximately 29,000 Americans. Primary sclerosing cholangitis, or PSC, is a condition that damages the ducts that carry digestive bile from the liver to the small intestine. Many individuals affected by this disease eventually require a liver transplant for continued survival.
MINNEAPOLIS – The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology® Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology.
William Eugene Mayberry, M.D., a distinguished Mayo Clinic physician, research scientist and administrator, passed away on Sept. 18 in Rochester, Minnesota. He was 87.
A popular geosciences mobile app, developed by the University of Minnesota, just received a major upgrade. The free Flyover Country app now includes 53 new field trip guides for Colorado and surrounding states, including almost 400 field trip stops.
New research from the Accessibility Observatory at the University of Minnesota estimates the impact of traffic congestion on access to jobs for the 50 largest (by population) metropolitan areas in the United States.
ROCHESTER, Minn. — When surgery and medication don’t help people with epilepsy, electrical stimulation of the brain has been a treatment of last resort. Unfortunately, typical approaches, such as vagal nerve stimulation or responsive nerve stimulation, rarely stop seizures altogether. But a new Mayo Clinic study in JAMA Neurology shows that seizures were suppressed in patients treated with continuous electrical stimulation.
ROCHESTER, Minn. — Each day, 78 people in the U.S. die of opioid overdoses, and more than 1,000 are treated in emergency departments for opioid misuse, federal figures show. In a series of broadcast-quality, 60-second videos available for media use, Mayo Clinic anesthesiologist and pain medicine expert W. Michael Hooten, M.D., and gastroenterologist Michael Camilleri, M.D., discuss the opioid epidemic and the dangers associated with inappropriate use of prescription pain medication.
MINNEAPOLIS – Women and minorities may be less likely to receive treatment for stroke, according to a study published in the September 14, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
While Zika remains a hot topic in the news, a new survey by Mayo Clinic reveals that Americans believe the country’s most significant health care challenge is cancer. In fact, the survey findings report “infectious diseases, such as Zika and Ebola,” are tied with HIV/AIDS as the least important health care challenges listed by respondents following cancer; obesity; neurological diseases, such as Alzheimer’s disease and amyotrophic lateral sclerosis; diabetes and heart disease.
While a prior history of suicide attempt is one of the strongest predictors of completed suicide, a Mayo Clinic study finds it is more lethal than previously known.
Andrew J. Haig, MD, will be presented the American Association of Neuromuscular & Electrodiagnostic Medicine’s (AANEM) 2016 Distinguished Researcher Award, at the AANEM 2016 Annual Meeting in New Orleans, LA, September 14-17, 2016.
Lawrence H. Phillips, II, MD, will be presented the American Association of Neuromuscular & Electrodiagnostic Medicine’s (AANEM) highest honor, the 2016 Lifetime Achievement Award, at the AANEM 2016 Annual Meeting in New Orleans, LA, September 14-17, 2016.
Enrica Arnaudo, MD, PhD, will be presented the American Association of Neuromuscular & Electrodiagnostic Medicine’s (AANEM) 2016 Advocacy Award, at the AANEM 2016 Annual Meeting in New Orleans, LA, September 14-17, 2016.
Robert C. Griggs, MD, will be presented the American Association of Neuromuscular & Electrodiagnostic Medicine’s (AANEM) 2016 Honorary Membership Award, at the AANEM 2016 Annual Meeting in New Orleans, LA, September 14-17, 2016.
Over 200 scientific abstracts were approved for presentation at the AANEM 2016 Annual Meeting held in New Orleans, LA, September 14-17, 2016. The AANEM Program Committee chose one outstanding abstract out of the hundreds to be honored with the Best Abstract Award.
Over 200 scientific abstracts were approved for presentation at the AANEM 2016 Annual Meeting held in New Orleans, LA, September 14-17, 2016. The AANEM Program Committee chose one outstanding abstract out of the hundreds to be honored with the Golseth Young Investigator Award.
John D. England, MD, will be presented the American Association of Neuromuscular & Electrodiagnostic Medicine’s (AANEM) 2016 Distinguished Physician Award, at the AANEM 2016 Annual Meeting in New Orleans, LA, September 14-17, 2016.
Several national surveys have found that approximately 15 to 20 percent of adults in the U.S. will report high levels of stress. A new study by Mayo Clinic researchers identified stress and burnout as a major problem employees face within the medical industry, leading to negative health behaviors. With rising stress levels in the workplace for employees, many companies are looking to integrate, engage and enroll employees into wellness programs.
MINNEAPOLIS – According to new research, women who are overweight or obese may have an increased risk of the most common kind of stroke, called ischemic stroke, but a decreased risk of a more often deadly stroke, called hemorrhagic stroke. The study is published in the September 7, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
ROCHESTER, Minn. — The Mayo Clinic Cancer Center has announced it is participating in the National Cancer Institute’s Molecular Analysis for Therapy Choice clinical trial, also known as NCI-MATCH or study EAY131. The Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive cancer center with locations in Rochester, Minnesota, Phoenix, Arizona, and Jacksonville, Florida. All three locations are participating.
Less than one year after President Barack Obama announced a White House Arctic Initiative that included better mapping of the area, a team of researchers led by the University of Minnesota Polar Geospatial Center released the first-ever publicly available set of high-resolution, three-dimensional topographic maps of the entire state of Alaska.
Mayo Clinic will offer the Zika virus antibody test developed by the Centers for Disease Control and Prevention (CDC).This test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and has been licensed to select national reference laboratories, including Mayo Medical Laboratories (MML).
The National Cancer Institute (NCI) awarded the University of Minnesota an $8.2 million Physical Sciences in Oncology Center (PS-OC) grant over the next five years to develop a cell migration simulator that will predict how cancer cells spread in the body leading to invasion and metastasis.
A number of common conditions are mistaken for multiple sclerosis (MS), a disabling central nervous system disease, say researchers at four academic medical centers across the U.S. in a study published online today in the journal Neurology.
MINNEAPOLIS – Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study. The research is published in the August 31, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. However, the drug valproate is associated with lower IQs in children, especially at higher dosages.
A new study led by the University of Minnesota shows that monkeys in captivity lose much of their native gut bacteria diversity and their gut bacteria ends up resembling those of humans. The results suggest that switching to a low-fiber, Western diet may have the power to deplete most normal primate gut microbes in favor of a less diverse set of bacteria.
ROCHESTER, Minn. – The glucocentric focus on lowering blood sugar in Type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper published by Mayo Clinic researchers in the journal Circulation: Cardiovascular Quality and Outcomes.
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
ROCHESTER, Minn. – In a paper published recently in the journal eLife, Mayo Clinic scientists take a step toward translating the protein BubR1’s function into a potential therapy for cancer.
Mayo Clinic continues to expand its national leadership in the telemedicine arena through its newly announced strategy of a converged emergency telemedicine practice. This positions Mayo Clinic to enhance the telemedicine services it offers to the more than 45 hospitals across nine states served by Mayo Clinic’s emergency telemedicine services.
Concern about a superbug gene with resistance to an antibiotic of last resort surfaced this summer among some health and infectious disease experts. A recent study in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology, found bacteria resistant to colistin in a second patient in the U.S. Though rare, resistance to colistin may leave health providers with few options for fighting bacterial infections in affected patients. What should you know?
According to a new study, calcium supplements may be associated with an increased risk of dementia in older women who have had a stroke or other signs of cerebrovascular disease. The research is published in the August 17, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Mayo Clinic, along with other members of the Geroscience Network, has published six manuscripts that map strategies for taking new drugs that target processes underlying aging into clinical trials. Researchers believe that these agents hold promise for treating multiple age-related diseases and disabilities. The articles appear today in The Journals of Gerontology: Series A – Biological Sciences and Medical Sciences.
On Tuesday, August 23, 2016, the University of Minnesota Technological Leadership Institute (TLI) will host an open meeting of the U.S. Commission on Enhancing National Cybersecurity. The University of Minnesota is one of just five locations where the Commission is hosting meetings.
Researchers at Mayo Clinic have reported a causal link between senescent cells — cells that accumulate with age and contribute to frailty and disease — and osteoarthritis in mice.
MINNEAPOLIS – Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Mayo Clinic has launched a new type of blood test that will be used to predict adverse cardiovascular events in patients with progressing coronary artery disease (CAD). The test measures blood concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular disease processes.
ROCHESTER, Minn — An international research team led by Mayo Clinic has developed a first-of-its-kind model to predict mortality in patients suffering from celiac disease (CD).
PHOENIX and TEMPE, Ariz. — Mayo Clinic and Arizona State University’s (ASU) research leadership announce the launch of a new grant program that will team up research scientists and clinicians from both institutions to develop transformative solutions for patients.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right